Trial intelligence / Profile preview

IVIG for Post-Polio Syndrome

NCT01537575Phase 3Completed

Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Start
Jan 2008
Primary completion
Dec 2009
Modality
Recombinant Proteins and Enzymes
01

Overview

A Phase 3 trial of intravenous immunoglobulin G in post-polio syndrome (PPS), sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Started Jan 2008; status: completed.

02

Drugs

intravenous immunoglobulin G
03

Conditions

post-polio syndrome (PPS)

Beyond the preview

Go deeper on NCT01537575.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01537575.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call